Skip to content
10-Q

Quarterly Report

VERDE BIO HOLDINGS, INC. APHD

0001096906-23-002376

← back to feed
Filed
Dec 15, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Dec 11, 2023 1.84B sh
Capex Q2 2024 · Oct 31, 2023 $0
Capex Q2 2024 · Oct 31, 2022 $6.99K
Operating Cash Flow Q2 2024 · Oct 31, 2023 −$628.88K
Operating Cash Flow Q2 2024 · Oct 31, 2022 −$410.48K
Stockholders Equity Q2 2024 · Oct 31, 2023 $1.54M
Stockholders Equity Q2 2024 · Jul 31, 2023 $1.89M
Stockholders Equity Q2 2024 · Apr 30, 2023 $2.21M
Stockholders Equity Q2 2024 · Oct 31, 2022 $3.05M
Stockholders Equity Q2 2024 · Jul 31, 2022 $3.14M
Stockholders Equity Q2 2024 · Apr 30, 2022 $3.59M
Total Liabilities Q2 2024 · Oct 31, 2023 $2.01M
Total Liabilities Q2 2024 · Apr 30, 2023 $1.84M
Current Assets Q2 2024 · Oct 31, 2023 $111.16K
Current Assets Q2 2024 · Apr 30, 2023 $97.75K
Total Assets Q2 2024 · Oct 31, 2023 $3.7M
Total Assets Q2 2024 · Apr 30, 2023 $4.16M
Net Income Q2 2024 · Oct 31, 2023 −$350.83K
Net Income Q2 2024 · Oct 31, 2023 −$687.47K
Net Income Q2 2024 · Oct 31, 2022 −$154.32K
Net Income Q2 2024 · Oct 31, 2022 −$940.93K
Operating Income Q2 2024 · Oct 31, 2023 −$303.33K
Operating Income Q2 2024 · Oct 31, 2023 −$630.28K
Operating Income Q2 2024 · Oct 31, 2022 −$125.28K
Operating Income Q2 2024 · Oct 31, 2022 −$823.74K